Preferred Label : Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;
Symbol : FTDALS1;
CISMeF acronym : ALSFTD; FTDALS; FTDALS1; FTDMND;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : ALSFTD; FTDMND; FTDALS; Frontotemporal dementia and/or amyotrophic lateral sclerosis; Amyotrophic lateral sclerosis and/or frontotemporal dementia; Frontotemporal dementia and/or motor neuron disease;
Description : Frontotemporal dementia (FTD) and/or amyotrophic lateral sclerosis (ALS) is an autosomal
dominant neurodegenerative disorder characterized by adult onset of one or both of
these features in an affected individual, with significant intrafamilial variation.
The disorder is genetically and pathologically heterogeneous (summary by Vance et
al., 2006). Patients with C9ORF72 repeat expansions tend to show a lower age of onset,
shorter survival, bulbar symptom onset, increased incidence of neurodegenerative disease
in relatives, and a propensity toward psychosis or hallucinations compared to patients
with other forms of ALS and/or FTD (summary by Harms et al., 2013). Patients with
C9ORF72 repeat expansions also show psychiatric disturbances that may predate the
onset of dementia (Meisler et al., 2013; Gomez-Tortosa et al., 2013). For a general
phenotypic description of frontotemporal dementia, also known as frontotemporal lobar
degeneration (FTLD), see 600274. For a general discussion of motor neuron disease
(MND), see amyotrophic lateral sclerosis-1 (ALS1; 105400).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by an expanded hexanucleotide repeat (GGGGCC)n in the chromosome 9 open reading
frame 72 gene (C9ORF72, 614260.0001);
Prefixed ID : #105550;
Origin ID : 105550;
UMLS CUI : C5779877;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT